P1599: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND CONCOMITANT COVID-19 INFECTION

• Y. Polyakov,
• K. Kaluzhskaya,
• E. Baryakh,
• E. Gemdzhian,
• E. Misyurina,
• E. Zhelnova,
• K. Yatskov,
• O. Kochneva,
• S. Andreev,
• T. Chudnova,
• D. Ivanova,
• T. Tolstykh

Affiliations

Y. Polyakov

1 Moscow City Clinical Hospital 52

K. Kaluzhskaya

1 Moscow City Clinical Hospital 52

E. Baryakh

1 Moscow City Clinical Hospital 52

E. Gemdzhian

4 National Research Center for Hematology, Moscow, Russia

E. Misyurina

1 Moscow City Clinical Hospital 52

E. Zhelnova

1 Moscow City Clinical Hospital 52

K. Yatskov

1 Moscow City Clinical Hospital 52

O. Kochneva

1 Moscow City Clinical Hospital 52

S. Andreev

1 Moscow City Clinical Hospital 52

T. Chudnova

1 Moscow City Clinical Hospital 52

D. Ivanova

1 Moscow City Clinical Hospital 52

T. Tolstykh

1 Moscow City Clinical Hospital 52